| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 03/17/2004 | CN1481823A Dietary supplements beneficial for the liver |
| 03/17/2004 | CN1481783A Medicine-carring particulates composed of hydrophilic resin and hydrophobic resin and its preparation method |
| 03/17/2004 | CN1481782A Emulsifying method for preparing emulsion and associated suspension and particles |
| 03/17/2004 | CN1481781A Injectable microdispersions for medical applications |
| 03/17/2004 | CN1481722A Dietary supplements for improving memory |
| 03/17/2004 | CN1142212C Coating and agglomerant for oral or dermal dosage forms |
| 03/17/2004 | CN1141981C Sponge material capable of promoting healing of spinal tissue wound, its preparing method and use |
| 03/17/2004 | CN1141875C Use of aerogel in agriculture |
| 03/16/2004 | US6706922 Process of making a compound by forming a polymer from a template drug |
| 03/16/2004 | US6706892 Adminstering maleimide derivative to covalently bond protein; wound healing, antibiotic, antiinflammatory, anticarcinogenic, hypotensive, and analgesic agents |
| 03/16/2004 | US6706877 Combining with vigorous stirring catalytically active mixture of alkali metal carbonate and fatty acid lower alkyl ester with emulsifier mixture of glycose component and carbohydrate partial ester to form emulsion/dispersion |
| 03/16/2004 | US6706836 Addition copolymerization of 2-hydroxyethyl methacrylate in ethylene glycol dimethacrylate and (meth)acrylic acid |
| 03/16/2004 | US6706737 Inhibiting gastric acid secretion are known in the art and include a class of benzimidazole- substituted compounds, one of which is omeprazole |
| 03/16/2004 | US6706728 Topical cervix immune response modifiers of imidazoquinoline amines, imidazopyridine amines, imidazonaphthyridine amines, oxazoloquinoline amines, and thiazoloquinoline amines |
| 03/16/2004 | US6706713 Conjugate for treating inflammatory infectious and/or skin diseases |
| 03/16/2004 | US6706708 Cytotoxic agents comprising taxanes and their therapeutic use |
| 03/16/2004 | US6706695 Antilipemic formulation |
| 03/16/2004 | US6706690 Hemoactive compositions and methods for their manufacture and use |
| 03/16/2004 | US6706681 Stabilised with mannitol |
| 03/16/2004 | US6706488 Antigenic compound for use in the treatment,and diagnosis of cancer |
| 03/16/2004 | US6706394 Method and apparatus for manufacture of magnetizable microparticles |
| 03/16/2004 | US6706289 Methods and compositions for enhanced delivery of bioactive molecules |
| 03/16/2004 | US6706287 Microencapsulated or enteric coated composition comprising a probiotic, a prebiotic, and an ammoniaphilic urea degrading microorganism with high alkaline ph stability and high urease activity |
| 03/16/2004 | US6706285 Enteric coated formulation of a benzimidazole derivative and method for preparation thereof |
| 03/16/2004 | US6706281 Melt-extrusion multiparticulates |
| 03/16/2004 | US6706280 Drug targeting with liposomes and magnetic resonance imaging contrast media for diagnostics |
| 03/16/2004 | US6706276 Compositions and methods for trapping and inactivating pathogenic microbes and spermatozoa |
| 03/16/2004 | US6706255 Liquid pharmaceutical compositions comprising thyroid hormones |
| 03/16/2004 | CA2331446C Biodegradable sustained-release alginate gels |
| 03/16/2004 | CA2265651C Immediate wettability water soluble film or water soluble layer for oral application |
| 03/16/2004 | CA2223745C Method of solubilizing, purifying, and refolding protein |
| 03/11/2004 | WO2004020969A2 Production of nanoparticles having a defined number of ligands |
| 03/11/2004 | WO2004020635A1 Bacteriophages and remedies for bacterial infection |
| 03/11/2004 | WO2004020623A2 Method for producing biodegradable, functionalised polymer particles, and use of the same as medicament carriers |
| 03/11/2004 | WO2004020552A1 Radical reaction inhibitors, method for inhibition of radical reactions, and use thereof |
| 03/11/2004 | WO2004020474A1 Lignan complexes |
| 03/11/2004 | WO2004020468A2 Interferon beta-like molecules for treatment of cancer |
| 03/11/2004 | WO2004020454A2 Modified transferrin fusion proteins comprising duplicate transferrin amino or carboxy terminal domains |
| 03/11/2004 | WO2004020435A1 Piperidinyl compounds that selectively bind integrins |
| 03/11/2004 | WO2004020405A2 Modified transferrin fusion proteins |
| 03/11/2004 | WO2004020404A2 Modified transferin-antibody fusion proteins |
| 03/11/2004 | WO2004020400A1 Enzyme activated self-immolative n-substituted nitrogen mustard prodrugs |
| 03/11/2004 | WO2004020289A1 Process for producing metered dose inhaler formulations |
| 03/11/2004 | WO2004020014A2 Method of controlling pharmacokinetics of immunomodulatory compounds |
| 03/11/2004 | WO2004019993A1 Self-immolative dendrimers releasing many active moieties upon a single activating event |
| 03/11/2004 | WO2004019992A1 Modified saccharides, conjugates thereof, and their manufacture |
| 03/11/2004 | WO2004019991A2 Scatter factor/hepatocyte growth factor antagonist nk4 for the treatment of glioma |
| 03/11/2004 | WO2004019990A1 Therapeutic system targeting pathogen proteases and uses thereof |
| 03/11/2004 | WO2004019989A1 Inclusion compound of nateglinide |
| 03/11/2004 | WO2004019988A1 Adhesive patch |
| 03/11/2004 | WO2004019987A1 Adhesive patch |
| 03/11/2004 | WO2004019985A1 Pharmaceutical products and compositions comprising specific anticholinergic agents, beta-2 agonists and corticosteroids |
| 03/11/2004 | WO2004019957A1 Medicinal composition for periodontal pocket administration containing bisphosphonic acid derivative or its salt as the active ingredient |
| 03/11/2004 | WO2004019955A1 The use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis |
| 03/11/2004 | WO2004019930A1 Pasting agent |
| 03/11/2004 | WO2004019929A1 Composition based on triethyl citrate for the treatment of bacterial infections of the skin |
| 03/11/2004 | WO2004019918A1 Granulate or powder for producing coating or binding agents for medicaments |
| 03/11/2004 | WO2004019907A1 Methods and reagents for treating infections of clostridium difficile and diseases associated therewith |
| 03/11/2004 | WO2004019905A1 Buccal, polar and non-polar spray or capsule containing drugs for treating muscular and skeletal disorders |
| 03/11/2004 | WO2004019904A1 Buccal, polar and non-polar spray or capsule containing drugs for treating allergies or asthma |
| 03/11/2004 | WO2004019902A1 Adhesive gel composition for iontophoresis preparation and process for producing the same |
| 03/11/2004 | WO2004019878A2 Adzymes and uses thereof |
| 03/11/2004 | WO2004019870A2 Breath freshening and oral cleansing product using salicylaldehyde |
| 03/11/2004 | WO2004019867A2 Breath freshening and oral cleansing product using cardamom oil |
| 03/11/2004 | WO2004019860A2 Formulations of modified antibodies and methods of making the same |
| 03/11/2004 | WO2004019800A2 Breath freshening and oral cleansing product |
| 03/11/2004 | WO2004019758A2 Methods of treating idiopathic pulmonary fibrosis |
| 03/11/2004 | WO2004004705A3 Pharmaceutical formulations for preparing drink products |
| 03/11/2004 | WO2004002444A3 A platform for transdermal formulations (ptf) |
| 03/11/2004 | WO2004000219A3 Stabilized formulations of alpha adrenergic receptor antagonists and uses thereof |
| 03/11/2004 | WO2003105768A3 Methods of reducing hypoglycemic episodes in the treatment of diabetes mellitus |
| 03/11/2004 | WO2003099200A3 Composition and method for the treatment of diaper rash using natural products |
| 03/11/2004 | WO2003096782A3 Process for preparing maytansinol |
| 03/11/2004 | WO2003094929A3 Preblocking with non-ha gags increases effectiveness of ha conjugated anticancer agents |
| 03/11/2004 | WO2003093449A3 Methods for delivery of nucleic acids |
| 03/11/2004 | WO2003084520A3 Pharmaceutical preparation containing oxycodone and naloxone |
| 03/11/2004 | WO2003084504A3 Matrix for sustained, invariant and independent release of active compounds |
| 03/11/2004 | WO2003072020A9 Therapeutical polyanhydride compounds for drug delivery |
| 03/11/2004 | WO2003070966A3 RNA INTERFERENCE MEDIATED TARGET DISCOVERY AND TARGET VALIDATION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 03/11/2004 | WO2003068268A3 Treatment, diagnosis and imaging of disease |
| 03/11/2004 | WO2003066585A3 Polymer-based compositions for sustained release |
| 03/11/2004 | WO2003066003A3 Anti-pathogen treatements |
| 03/11/2004 | WO2003059394A3 Composition for transporting oligonucleotides through the blood brain barrier and their use for treating central nervous system diseases |
| 03/11/2004 | WO2003059323A3 Stable salts of o-acetylsalicylic acid containing basic amino acids ii |
| 03/11/2004 | WO2003057838A3 Antibodies against the muc18 antigen |
| 03/11/2004 | WO2003057133A3 Herbal composition for treating various disorders including psoriasis, a process for preparation thereof and method for treatment of such disorders |
| 03/11/2004 | WO2003047532A3 Compositions and methods for the therapeutic use of an atonal-associated sequence for a gastrointestinal condition |
| 03/11/2004 | WO2003045350A3 Device for incorporating substances which contain a sea sponge as a support |
| 03/11/2004 | WO2003027135A3 Mutated anti-cd22 antibodies with increased affinity to cd22-expressing leukemia cells |
| 03/11/2004 | WO2003015690B1 Method for treating primary insomnia |
| 03/11/2004 | WO2003014316A3 Immunomodulatory compositions, formulations, and methods for use thereof |
| 03/11/2004 | WO2003006608A3 Enhancement of transfection of dna into the liver |
| 03/11/2004 | WO2003000191A3 Composition comprising glycosaminogycans and hyaluronidase inhibitors for the treatment of arthritic joints |
| 03/11/2004 | WO2002087624A3 Uses of chemically-modified cholinesterases for detoxification of organophosphorus compounds |
| 03/11/2004 | WO2002082462A3 Stabilization and terminal sterilization of phospholipid formulations |
| 03/11/2004 | WO2002070594A8 A method of preparing a collagen sponge, a device for extracting a part of a collagen foam, and an elongated collagen sponge |
| 03/11/2004 | WO2002058750A8 A suspension comprising fibrinogen, thrombin and alcohol and a method of coating a carrier with the same |
| 03/11/2004 | WO2002058749A8 Carrier with solid fibrinogen and solid thrombin |
| 03/11/2004 | US20040049265 Drug coating with topcoat |
| 03/11/2004 | US20040049187 Self-adhesive hydratable matrix for topical therapeutic use |